Lance Friedman 13D/13G Filings for Aspire Biopharma Holdings, Inc. (ASBP)

Lance Friedman 13D and 13G filings for Aspire Biopharma Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-06
8:47 pm
Purchase
2026-08-0413GASPIRE BIOPHARMA HLDGS INC
ASBP
Lance Friedman3,979,709
7.920%
3,977,869increase
(+216188.53%)
Filing